Clinical features, haemodynamics, and outcomes of heart failure with preserved ejection fraction in coarctation of aorta

被引:1
作者
Egbe, Alexander C. [1 ]
Reddy, Yogesh N. V. [1 ]
Ali, Ahmed E. [1 ]
Younis, Ahmed [1 ]
Borlaug, Barry A. [1 ]
机构
[1] Mayo Clin, Dept Cardiovasc Med, 200 First St SW, Rochester, MN 55905 USA
关键词
Heart failure; Mortality; Prognostication; LEFT-VENTRICULAR HYPERTROPHY; REPAIRED COARCTATION; BLOOD-PRESSURE; HYPERTENSION; DYSFUNCTION; ADULTS; STRAIN;
D O I
10.1002/ejhf.3379
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims There are similarities in the pathogenesis of cardiac remodelling and dysfunction in heart failure with preserved ejection fraction (HFpEF) and coarctation of aorta (COA). We hypothesized that clinical HFpEF would be highly prevalent in adults with COA, and that the presence of HFpEF would increase the risk of mortality in this population. The aim of this study was to define the clinical features, haemodynamics, and prognostic implications of HFpEF in COA. Methods and results Consecutive adults with repaired COA that underwent right heart catheterization were identified retrospectively. HFpEF was defined as heart failure symptoms (exertional dyspnoea or fatigue), preserved left ventricular ejection fraction >= 50%, and pulmonary artery wedge pressure at rest >15 mmHg. Of 99 COA patients, 32 (32%) had HFpEF. The correlates of HFpEF were obesity (adjusted odds ratio [OR] 4.15, 95% confidence interval [CI] 1.31-13.2), atrial fibrillation (adjusted OR 3.13, 95% CI 1.00-10.7), total arterial compliance index (adjusted OR 0.12, 95% CI 0.06-0.41 per 1 ml/mmHg*m(2)), and pulmonary artery compliance index (adjusted OR 0.36, 95% CI 0.15-0.56 per 1 ml/mmHg*m(2)). Of 99 patients, 24 (24%) died and 5 (5%) underwent heart transplant. The 10-year cumulative incidence of death/transplant was higher in COA patients with HFpEF compared with patients without HFpEF (39% vs. 12%, p = 0.001). The presence of HFpEF was associated with increased risk of death/transplant (adjusted hazard ratio 1.68, 95% CI 1.16-3.11). Conclusions Heart failure with preserved ejection fraction is common in adults with COA and is associated with greater risk of death/transplant, emphasizing a pressing need for interventions to prevent and treat HFpEF in COA.
引用
收藏
页码:2595 / 2603
页数:9
相关论文
共 50 条
  • [21] Heart failure with preserved ejection fraction
    Rigolli, Marzia
    Whalley, Gillian A.
    JOURNAL OF GERIATRIC CARDIOLOGY, 2013, 10 (04) : 369 - 376
  • [22] Comparison of Clinical Outcomes of Patients With Acute Heart Failure and Recovered Ejection Fraction versus Preserved or Reduced Ejection Fraction
    Cho, Jae Yeong
    Kim, Kye Hun
    Lee, Sang Eun
    Cho, Hyun Jai
    Lee, Hae-Yeoung
    Choi, Jin-Oh
    Jeon, Eun-Seok
    Kim, Min-Seok
    Kim, Jae-Joong
    Hwang, Kyung-Kuk
    Chae, Shung Chull
    Baek, Sang Hong
    Kang, Seok-Min
    Choi, Dong-Ju
    Yoo, Byung-Su
    Ahn, Youngkeun
    Park, Hyun-Young
    Cho, Myeong-Chan
    Oh, Byung-Hee
    CIRCULATION, 2017, 136
  • [23] Adiposity and clinical outcomes in East Asian patients with heart failure and preserved ejection fraction
    Seki, Yuko
    Obokata, Masaru
    Harada, Tomonari
    Kagami, Kazuki
    Sorimachi, Hidemi
    Saito, Yuki
    Kato, Toshimitsu
    Ishii, Hideki
    IJC HEART & VASCULATURE, 2023, 44
  • [24] Natriuretic Peptides, Kidney Function, and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction
    Neuen, Brendon L.
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Beldhuis, Iris
    Myhre, Peder
    Desai, Akshay S.
    Skali, Hicham
    Causland, Finnian R. Mc
    Mcgrath, Martina
    Anand, Inder
    Zile, Michael R.
    Pfeffer, Marc A.
    Mcmurray, John J. V.
    Solomon, Scott D.
    JACC-HEART FAILURE, 2025, 13 (01) : 28 - 39
  • [25] Sex Differences in Clinical Characteristics and Outcomes in Elderly Patients With Heart Failure and Preserved Ejection Fraction The Irbesartan in Heart Failure With Preserved Ejection Fraction (I-PRESERVE) Trial
    Lam, Carolyn S. P.
    Carson, Peter E.
    Anand, Inder S.
    Rector, Thomas S.
    Kuskowski, Michael
    Komajda, Michel
    McKelvie, Robert S.
    McMurray, John J.
    Zile, Michael R.
    Massie, Barry M.
    Kitzman, Dalane W.
    CIRCULATION-HEART FAILURE, 2012, 5 (05) : 571 - 578
  • [26] Epidemiological and clinical boundaries of heart failure with preserved ejection fraction
    Gentile, Francesco
    Ghionzoli, Nicolo
    Borrelli, Chiara
    Vergaro, Giuseppe
    Pastore, Maria Concetta
    Cameli, Matteo
    Emdin, Michele
    Passino, Claudio
    Giannoni, Alberto
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (08) : 1233 - 1243
  • [27] The Clinical Significance of Pulse Pressure in Patients With Heart Failure With Preserved Ejection Fraction
    Tokitsu, Takanori
    Yamamoto, Eiichiro
    Hirata, Yoshihiro
    Fujisue, Koichiro
    Sugamura, Koichi
    Yamamuro, Megumi
    Kaikita, Koichi
    Hokimoto, Seiji
    Sugiyama, Seigo
    Ogawa, Hisao
    CIRCULATION, 2015, 132
  • [28] Outcomes in Patients With Heart Failure With Preserved Ejection Fraction It Is More Than the Heart
    Kitzman, Dalane W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 59 (11) : 1006 - 1007
  • [29] Biatrial myopathy in heart failure with preserved ejection fraction
    Omote, Kazunori
    Sorimachi, Hidemi
    Obokata, Masaru
    Verbrugge, Frederik H.
    Omar, Massar
    Popovic, Dejana
    Reddy, Yogesh N. V.
    Pislaru, Sorin V.
    Pellikka, Patricia A.
    Borlaug, Barry A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (02) : 288 - 298
  • [30] Heart Failure With Preserved Ejection Fraction: Prevention and Management
    Cilia, Lindsey
    Saeed, Anum
    Ganga, Harsha V.
    Wu, Wen-Chih
    AMERICAN JOURNAL OF LIFESTYLE MEDICINE, 2019, 13 (02) : 182 - 189